Clinical Trial Update: Estrogen Administration for the Treatment of NASH in Postmenopausal Women [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is investigating estrogen administration as a treatment for nonalcoholic steatohepatitis (NASH) in postmenopausal women; the study is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis

Drugs mentioned

• Estrogen (Estrogen)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: NASH - Nonalcoholic Steatohepatitis | Phase 3 | Status: RECRUITING